<DOC>
	<DOCNO>NCT02513290</DOCNO>
	<brief_summary>The purpose study verify whether difference health-related quality life patient allergic rhinitis treat bilastine 20 mg compare treat loratadine 10 mg .</brief_summary>
	<brief_title>Quality Life Patients With Allergic Rhinitis : Clinical Trial With Bilastine Loratadine</brief_title>
	<detailed_description>This prospective randomize double-blinded study , patient recruit august 2013 august 2014 . Outpatients attend 4 otolaryngology clinic Crici√∫ma , state Santa Catarina , Brazil invite participate study . They age 18 63 year . Seventy-three patient include , 36 treat loratadine 10 mg 37 bilastine 20 mg medication administer day ten day . The primary outcome quality life , assess modify Rhinoconjunctivitis Quality Life Questionnaire ( RQLQm ) , apply baseline 10 day treatment .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>clinical diagnosis allergic rhinitis ( typical history rhinitis symptom : coryza , sneeze , nasal obstruction , nasal itching , eye symptom , hypersensitivity test specific IgE measure Radioallergosorbent Test ( RAST ) skin test patient classify intermittent rhinitis ( symptom less 4 day per week ) persistent rhinitis ( symptoms 4 day per week ) moderate severe intensity ( annoyance impair quality quantity sleep interfere daily activity ) pregnancy breastfeed ; nonallergic rhinitis ( vasomotor , infectious druginduced ) ; know hypersensitivity antihistamine ; clinical disorder might affect assessment ; nasal disease could lead complete blockage one nostrils blockage , tumor septal deviation ; therapy immunotherapy ; use antihistamine disodium cromoglycate within past four week ; use topical systemic corticosteroid , immunosuppressant investigational drug within last two week ; use topical antihistamine nasal decongestant within last 48 hour ; use deposit steroid within last month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>quality life</keyword>
	<keyword>allergic rhinitis</keyword>
	<keyword>bilastine</keyword>
	<keyword>loratadine</keyword>
	<keyword>clinical trial</keyword>
</DOC>